Nigeria receives Lenacapavir, a new twice-yearly HIV prevention injection. This long-acting PrEP aims to improve adherence ...

Nigeria has received a consignment of long-acting injectable Lenacapavir for HIV prevention, marking a significant step in the country’s efforts to curb new infections and expand access to innovative ...

A recent experimental treatment may offer a new method to prevent HIV infection: by combining two antiviral tactics into a single antibody. In laboratory studies, the new molecule forced the virus to ...

While the rate of HIV in Kampala, Uganda, is more than double the national average, a recent survey of displaced youths in ...

Public health advocates in the Baton Rouge area are working to break the stigma surrounding HIV, while connecting the community with lifesaving resources.

Local organizations say women are often left out of HIV conversations, even though they make up a significant portion of people living with the virus.

Although HIV infection remains a global public health challenge, ART has transformed it from a fatal illness to a manageable lifetime condition for those who are successfully being treated.Initially, ...

People affected by human immunodeficiency virus (HIV), which causes AIDS, did not develop more severe forms of mpox than HIV-negative people during the multiregional outbreak of this disease that ...

The philanthropic arm of a major pharmaceutical company gave several Dallas-based nonprofits hundreds of thousands of dollars ...

Kenya's health authorities have begun administering lenacapavir, a long-acting HIV prevention drug delivered by injection ...

Significant PrEP underutilization remains, with ~600,000 US users versus an estimated 2.2 million who could benefit, largely due to low awareness, stigma, and misconceptions about HIV risk. Yeztugo is ...

Funding shortfalls prompt 18 states to cut costs, jeopardizing care for tens of thousands of Americans living with HIV.